<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-06T14:37:52Z</responseDate>
  <request identifier="oai:figshare.com:article/34073009" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34073009</identifier>
        <datestamp>2026-10-05T17:43:06Z</datestamp>
        <setSpec>category_8</setSpec>
        <setSpec>category_13</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_24</setSpec>
        <setSpec>category_272</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_128</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>category_134</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Delamanid (DLM) and pretomanid (Pa) minimum inhibitory concentrations (MICs), genomic variants, lineage, and clinical characteristics of 17 &lt;i&gt;Mycobacterium tuberculosis&lt;/i&gt; isolates included in the study.&lt;/p&gt;</dc:title>
          <dc:creator>Ana Tsutsunava (22624112)</dc:creator>
          <dc:creator>Nestani Tukvadze (333421)</dc:creator>
          <dc:creator>Zaza Avaliani (7517621)</dc:creator>
          <dc:creator>Galo A. Goig (8286999)</dc:creator>
          <dc:creator>Levan Jugheli (476405)</dc:creator>
          <dc:creator>Sebastien Gagneux (149824)</dc:creator>
          <dc:creator>Russell R. Kempker (7348955)</dc:creator>
          <dc:creator>Nino Maghradze (7517618)</dc:creator>
          <dc:subject>Microbiology</dc:subject>
          <dc:subject>Genetics</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Evolutionary Biology</dc:subject>
          <dc:subject>Environmental Sciences not elsewhere classified</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Hematology</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>Virology</dc:subject>
          <dc:subject>whole genome sequencing</dc:subject>
          <dc:subject>resazurin microtiter assay</dc:subject>
          <dc:subject>rapid molecular diagnostics</dc:subject>
          <dc:subject>div &gt;&lt; p</dc:subject>
          <dc:subject>47 %) manifested</dc:subject>
          <dc:subject>2021 – 2024</dc:subject>
          <dc:subject>minimum inhibitory concentrations</dc:subject>
          <dc:subject>remaining nine isolates</dc:subject>
          <dc:subject>hinder resistance detection</dc:subject>
          <dc:subject>isolates phenotypically resistant</dc:subject>
          <dc:subject>mycobacterium tuberculosis &lt;/</dc:subject>
          <dc:subject>results support dlm</dc:subject>
          <dc:subject>routine pdst using</dc:subject>
          <dc:subject>identify mutations associated</dc:subject>
          <dc:subject>pa resistance association</dc:subject>
          <dc:subject>dlm concentration range</dc:subject>
          <dc:subject>pa resistance (&lt;</dc:subject>
          <dc:subject>resistant tuberculosis</dc:subject>
          <dc:subject>critical concentrations</dc:subject>
          <dc:subject>determined using</dc:subject>
          <dc:subject>broader range</dc:subject>
          <dc:subject>three isolates</dc:subject>
          <dc:subject>w678g mutations</dc:subject>
          <dc:subject>conferring mutations</dc:subject>
          <dc:subject>emerging resistance</dc:subject>
          <dc:subject>drug resistance</dc:subject>
          <dc:subject>mtb &lt;/</dc:subject>
          <dc:subject>fgd1 &lt;/</dc:subject>
          <dc:subject>fbic &lt;/</dc:subject>
          <dc:subject>ddn &lt;/</dc:subject>
          <dc:subject>pa resistance</dc:subject>
          <dc:subject>wgs ).</dc:subject>
          <dc:subject>treatment outcomes</dc:subject>
          <dc:subject>threatens drug</dc:subject>
          <dc:subject>standardization challenges</dc:subject>
          <dc:subject>respectively ).</dc:subject>
          <dc:subject>one carrying</dc:subject>
          <dc:subject>mic value</dc:subject>
          <dc:description>&lt;p&gt;Delamanid (DLM) and pretomanid (Pa) minimum inhibitory concentrations (MICs), genomic variants, lineage, and clinical characteristics of 17 &lt;i&gt;Mycobacterium tuberculosis&lt;/i&gt; isolates included in the study.&lt;/p&gt;</dc:description>
          <dc:date>2026-10-05T17:43:00Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pone.0359717.t001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Delamanid_DLM_and_pretomanid_Pa_minimum_inhibitory_concentrations_MICs_genomic_variants_lineage_and_clinical_characteristics_of_17_i_Mycobacterium_tuberculosis_i_isolates_included_in_the_study_p_/34073009</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
